Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

Yu Tzu Tai, Betty Y. Chang, Sun Young Kong, Mariateresa Fulciniti, Guang Yang, Yolanda Calle, Yiguo Hu, Jianhong Lin, Jian Jun Zhao, Antonia Cagnetta, Michele Cea, Michael A. Sellitto, Mike Y. Zhong, Qiuju Wang, Chirag Acharya, Daniel R. Carrasco, Joseph J. Buggy, Laurence Elias, Steven P. Treon, William MatsuiPaul Richardson, Nikhil C. Munshi, Kenneth C. Anderson

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences